Drugs / MDMA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01211405 | Nov 2010 → Jun 2015 | post-traumatic stress disorder | Resilient Pharmaceuticals | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MDMA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01211405 ↗ |
| Route | Oral | “MDMA was administered orally in two 8-h sessions with concomitant manualised psychotherapy.” PMID 29728331 ↗ May 2018 |